China Hepatitis B Vaccine Industry 2013 Deep Research Report

Researchmoz.us announces that a new market research report is available in its catalogue: China Hepatitis B Vaccine Industry 2013 Deep Research Report. 2013 Deep Research Report on China Hepatitis B Vaccine Industry was professional and depth research report on China Hepatitis B Vaccine industry. 

This report has firstly introduced Hepatitis B Vaccine definition classification industry chain etc related information. Then introduced Hepatitis B Vaccine manufacturing technology and product specifications, And then summary statistics China major Hepatitis B Vaccine manufacturers 2009-2013 Hepatitis B Vaccine capacity production supply demand shortage and Hepatitis B Vaccine selling price cost gross margin and production value, and also introduced China 8 manufacturers company basic information, 2009-2013 Hepatitis B Vaccine capacity production price cost gross margin production value China market share etc details information. 

In the end, this report introduced 10million pieces/year Hepatitis B Vaccine project feasibility analysis and investment return analysis, also give related research conclusions and development trend analysis. In a word, it was a depth research report on China Hepatitis B Vaccine industry. And thanks to the support and assistance from Hepatitis B Vaccine industry chain related experts and enterprises during Research Team survey and interviews.

Table of Content:

Chapter One Hepatitis B Vaccine Industry Overview 1

1.1 Definition 1

1.2 Classification Application Work Principle and Related Content 2

1.2.1 Classification 2

1.2.2 Vaccination Population 4

1.2.3 Vaccination Method 5

1.2.3 Work Principle 6

1.2.4 Vaccination Process and Effect 7

1.2.5 Vaccination Fee and Location 8

1.2.6 Vaccination Note 8

1.3 Industry Chain Structure 9

1.4 Market Status and Development Trend 7

1.4.1 Industry Competition Pattern 7

1.4.2 China Market Status 10

1.4.3 Market Development Trend 12

1.5 Policy Analysis 13

Chapter Two Hepatitis B Vaccine Manufacturing Process and Cost Analysis 19

2.1 Product Speficiation 19

2.2 Manufacturing Process Analysis 21

2.3 Cost Structure Analysis 22

2.4 Raw Materials and Equipments Overview 23

2.5 Technical Trend and Difficulties 23

Chapter Three Hepatitis B Vaccine Production Supply Sales Demand Market Status and Forecast 27

3.1 Hepatitis B Vaccine Capacity and Production 27

3.1.1 Saccharomyces Cerevisciae Hepatitis B Vaccine Capacity and Production 31

3.1.2 CHO Hepatitis B Vaccine 33

3.1.3 Hansenula Polymorpha Hepatitis B Vaccine 35

3.2 Hepatitis B Vaccine Different Type(Saccharomyces Cerevisiae:5ug 10ug  20ug  60ug,CHO Cell:10ug 20ug,Hansenula Polymorpha:10ug) Capacity and Production 38

3.2.1 Saccharomyces Cerevisciae Hepatitis B Vaccine (Type:5ug 10ug  20ug 60ug) 38

3.2.2 CHO Hepatitis B Vaccine (Type:10ug 20ug) 45

3.2.3 Hansenula Polymorpha Hepatitis B Vaccine (Type:10ug) 50

3.2.4 Capacity and Production Statistics 52

3.3 Children Adult Type Hepatitis B Vaccine Production Overview 58

3.3.1 Hepatitis B Vaccine (Children) 58

3.3.2Hepatitis B Vaccine (Adult) 60

3.3.3 Capacity and Production Statistics 61

3.4 Beijing Shenzhen Liaoning Hebei Shandong Henan etc Different Regions Hepatitis B Vaccine Production Overview 64

3.5 Hepatitis B Vaccine Capacity Utilization Rate Analysis 68

3.5.1Saccharomyces Cerevisciae Hepatitis B Vaccine 69

3.5.2 CHO Hepatitis B Vaccine 70

3.5.3 Hansenula Polymorpha Hepatitis B Vaccine 71

3.6 Hepatitis B Vaccine Demand Overview 71

3.7 Hepatitis B Vaccine Supply Demand Shortage 73

3.8 Hepatitis B Vaccine Cost Price Production Value Gross Margin 74

3.9Hepatitis B Vaccine Import Export Consumption 75

3.10 Hepatitis B Vaccine Batch Release Number Statistics 77

Chapter Four Hepatitis B Vaccine Key Manufacturers 98

4.1 Beijing Tiantan Biological Products Co.,Ltd (600161) 98

4.2 Shenzhen Kaitai Biological 109

4.3 Dalian Hissen Biological 114

4.4 NCPC GeneTech Biotechnology 120

4.5 Beijing Huaerdun Biotechnology 125

4.6 Hualan Biological(002007) 128

4.7 GSK 133

4.8 Berna Biotech 140

Chapter Five Hepatitis B Vaccine New Project Investment Feasibility Analysis 146

5.1 Hepatitis B Vaccine New Project SWOT Analysis 146

5.2 10 Million Pieces/Year Hansenula Polymorpha YeastHepatitis B Vaccine (Type:10ug) Project Investment Feasibility Analysis 146

5.2.1 Project Name 146

5.2.2 Product and Scale 146

5.2.3 Project Buildings 147

5.2.4 Project Schedule 147

5.2.5 Project Investment Feasibility Analysis 148

Find newly published market research reports for other industries @ Latest Repors

Contact: sales@researchmoz.us for further information.